IP Verse

Mylan Pharmaceuticals Inc. et al. vs Bayer Intellectual Property GmbH et al.

The detailed information for PTAB case with proceeding number IPR2018-01143 filed by Mylan Pharmaceuticals Inc. et al. against Bayer Intellectual Property GmbH et al. on May 24, 2018. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2018-01143
Filing Date: May 24, 2018
Petitioner: Mylan Pharmaceuticals Inc. et al.
Respondent: Bayer Intellectual Property GmbH et al.
Status: Institution Denied
Respondent Application Number: 11883218
Respondent Tech Center: 1600
Respondent Patent Number: 9539218
Institution Decision Date: Dec 3, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice of Refund	Feb 5, 2019	PAPER	BOARD
Petitioner's Request for Refund	Jan 16, 2019	PAPER	PETITIONER
DECISION - Granting Petitioner¿¿¿s Renewed Motion to Seal 37 C.F.R. ¿¿ 42.54	Jan 2, 2019	PAPER	BOARD
EX1067 - REVISED REDACTED - September 21, 2018 Mylan Letter to Judge Andrews	Dec 14, 2018	EXHIBIT	PETITIONER
EX1066 - REVISED REDACTED - September 18, 2018 Bayer Letter to Judge Andrews	Dec 14, 2018	EXHIBIT	PETITIONER
EX1068 - REVISED REDACTED - September 24, 2018 Bayer Letter to Judge Andrews	Dec 14, 2018	EXHIBIT	PETITIONER
Petitioner's Renewed Motion to Seal	Dec 14, 2018	PAPER	PETITIONER
Decision Denying Institution of Inter Partes Review	Dec 3, 2018	PAPER	BOARD
Decision Granting Petitioner's Motion for Entry of Stipulated Protective Order and Denying Without Prejudice Petitioner's Motion to Seal	Nov 30, 2018	PAPER	BOARD
Public Redacted Version of Patent Owner's Authorized Sur-Reply	Nov 29, 2018	PAPER	PATENT OWNER
Patent Owner's Authorized Sur-Reply	Oct 29, 2018	PAPER	PATENT OWNER
EX1067 - PROTECTIVE ORDER MATERIAL - September 21, 2018 Mylan Letter to Judge Andrews	Oct 22, 2018	EXHIBIT	PETITIONER
EX1068 - PROTECTIVE ORDER MATERIAL - September 24, 2018 Bayer Letter to Judge Andrews	Oct 22, 2018	EXHIBIT	PETITIONER
Petitioner's Pre-Institution Reply	Oct 22, 2018	PAPER	PETITIONER
EX1066 - PROTECTIVE ORDER MATERIAL - September 18, 2018 Bayer Letter to Judge Andrews	Oct 22, 2018	EXHIBIT	PETITIONER
EX1066 - REDACTED - September 18, 2018 Bayer Letter to Judge Andrews	Oct 22, 2018	EXHIBIT	PETITIONER
EX1067 - REDACTED - September 21, 2018 Mylan Letter to Judge Andrews	Oct 22, 2018	EXHIBIT	PETITIONER
EX1068 - REDACTED - September 24, 2018 Bayer Letter to Judge Andrews	Oct 22, 2018	EXHIBIT	PETITIONER
EX1069 - September 28, 2018 Order	Oct 22, 2018	EXHIBIT	PETITIONER
EX1070 - Stipulated Protective Order	Oct 22, 2018	EXHIBIT	PETITIONER
EX1071 - Stipulated Protective Order - Redline	Oct 22, 2018	EXHIBIT	PETITIONER
Petitioner's Motion to Seal Exhibits 1066-1068	Oct 22, 2018	PAPER	PETITIONER
Patent Owner's Preliminary Response	Sep 7, 2018	PAPER	PATENT OWNER
Patent Owner's Exhibit List	Sep 7, 2018	PAPER	PATENT OWNER
Ex. 2001 (Xarelto Prescribing Information)	Sep 7, 2018	EXHIBIT	PATENT OWNER
Ex. 2002 (Markman Order in 17-cv-462 (D. Del.))	Sep 7, 2018	EXHIBIT	PATENT OWNER
Ex. 2003 (Joint Claim Construction Brief in 17-cv-462 (D. Del.))	Sep 7, 2018	EXHIBIT	PATENT OWNER
Patent Owner's Power of Attorney	Jun 12, 2018	PAPER	PATENT OWNER
Patent Owner's Mandatory Notices Under 37 C.F.R. 42.8(a)(2)	Jun 12, 2018	PAPER	PATENT OWNER
Notice of Accord Filing Date	Jun 8, 2018	PAPER	BOARD
Power of Attorney - Mylan Pharmaceuticals Inc.	May 24, 2018	PAPER	PETITIONER
EX1001 US 9,539,218	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 1 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 2 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 3 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 4 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 5 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 7 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 9 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 10 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 6 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1004 File History of US 9,539,218 - Part 8 of 10	May 24, 2018	EXHIBIT	PETITIONER
EX1005 610 Publication	May 24, 2018	EXHIBIT	PETITIONER
EX1006 Kubitza Abstracts	May 24, 2018	EXHIBIT	PETITIONER
EX1008 US 7,157,456	May 24, 2018	EXHIBIT	PETITIONER
EX1009 US 7,592,339	May 24, 2018	EXHIBIT	PETITIONER
EX1010 Morales	May 24, 2018	EXHIBIT	PETITIONER
EX1014 Aulton	May 24, 2018	EXHIBIT	PETITIONER
EX1015 EPO Patentees Response	May 24, 2018	EXHIBIT	PETITIONER
EX1011 Isayev	May 24, 2018	EXHIBIT	PETITIONER
EX1012 Foerch	May 24, 2018	EXHIBIT	PETITIONER
EX1013 FDA-CDER Guidance for Industry 2002	May 24, 2018	EXHIBIT	PETITIONER
EX1007 Forsman	May 24, 2018	EXHIBIT	PETITIONER
EX1016 EPO Revocation Decision	May 24, 2018	EXHIBIT	PETITIONER
EX1017 Carville	May 24, 2018	EXHIBIT	PETITIONER
EX1021 Abstract Book	May 24, 2018	EXHIBIT	PETITIONER
EX1018 Leadley	May 24, 2018	EXHIBIT	PETITIONER
EX1019 Goldhaber	May 24, 2018	EXHIBIT	PETITIONER
EX1020 Perzborn	May 24, 2018	EXHIBIT	PETITIONER
EX1022 1985 Goodman and Gilman Chapter	May 24, 2018	EXHIBIT	PETITIONER
EX1023 Birkett Pharmacokinetics made easy	May 24, 2018	EXHIBIT	PETITIONER
EX1027 1999 Fragmin Label	May 24, 2018	EXHIBIT	PETITIONER
EX1030 Lieberman Excerpt	May 24, 2018	EXHIBIT	PETITIONER
EX1031 Roehrig Abstract	May 24, 2018	EXHIBIT	PETITIONER
EX1032 WO2003101423	May 24, 2018	EXHIBIT	PETITIONER
EX1035 Camerlingo	May 24, 2018	EXHIBIT	PETITIONER
EX1036 Golub	May 24, 2018	EXHIBIT	PETITIONER
EX1039 Ageno	May 24, 2018	EXHIBIT	PETITIONER
EX1040 Clinical Pharmacokinetics	May 24, 2018	EXHIBIT	PETITIONER
EX1024 Iskedjian	May 24, 2018	EXHIBIT	PETITIONER
EX1025 2000 Lovenox Label	May 24, 2018	EXHIBIT	PETITIONER
EX1026 Al-Yaseen	May 24, 2018	EXHIBIT	PETITIONER
EX1028 Yeager	May 24, 2018	EXHIBIT	PETITIONER
EX1029 Nutescu	May 24, 2018	EXHIBIT	PETITIONER
EX1033 Saccone	May 24, 2018	EXHIBIT	PETITIONER
EX1034 Wright	May 24, 2018	EXHIBIT	PETITIONER
EX1037 Bueller	May 24, 2018	EXHIBIT	PETITIONER
EX1038 Martineau	May 24, 2018	EXHIBIT	PETITIONER
EX1042 Weinz	May 24, 2018	EXHIBIT	PETITIONER
EX1043 Weitz	May 24, 2018	EXHIBIT	PETITIONER
EX1044 EP 1845961	May 24, 2018	EXHIBIT	PETITIONER
EX1045 Mann	May 24, 2018	EXHIBIT	PETITIONER
EX1046 Benet CV	May 24, 2018	EXHIBIT	PETITIONER
EX1049 Moonis	May 24, 2018	EXHIBIT	PETITIONER
EX1041 Eriksson	May 24, 2018	EXHIBIT	PETITIONER
EX1047 Benet	May 24, 2018	EXHIBIT	PETITIONER
EX1048 Kaiser	May 24, 2018	EXHIBIT	PETITIONER
EX1050 Remington	May 24, 2018	EXHIBIT	PETITIONER
EX1052 CV of Doherty	May 24, 2018	EXHIBIT	PETITIONER
EX1057 Refludan Label 2004	May 24, 2018	EXHIBIT	PETITIONER
EX1061 Xarelto Label 2012	May 24, 2018	EXHIBIT	PETITIONER
EX1062 Eliquis Label 2014	May 24, 2018	EXHIBIT	PETITIONER
EX1063 Savaysa Label 2015	May 24, 2018	EXHIBIT	PETITIONER
EX1051 Lowe	May 24, 2018	EXHIBIT	PETITIONER
EX1053 Complaint	May 24, 2018	EXHIBIT	PETITIONER
EX1054 USP Chapter 711	May 24, 2018	EXHIBIT	PETITIONER
EX1055 Bauer 2002	May 24, 2018	EXHIBIT	PETITIONER
EX1056 Coumadin Label 1999	May 24, 2018	EXHIBIT	PETITIONER
EX1058 Angiomax Label 2000	May 24, 2018	EXHIBIT	PETITIONER
EX1059 Acova Label 2000	May 24, 2018	EXHIBIT	PETITIONER
EX1060 Pradaxa Label 2015	May 24, 2018	EXHIBIT	PETITIONER
EX1064 Bevyxxa Label 2017	May 24, 2018	EXHIBIT	PETITIONER
EX1065 Email	May 24, 2018	EXHIBIT	PETITIONER
EX1003 Doherty Declaration	May 24, 2018	EXHIBIT	PETITIONER
EX1002 Benet Declaration	May 24, 2018	EXHIBIT	PETITIONER
Petition for Inter Partes Review of U.S. Patent No. 9,539,218	May 24, 2018	PAPER	PETITIONER